Acute lymphoblastic leukemia risk factors: Difference between revisions
Jump to navigation
Jump to search
Kamal Akbar (talk | contribs) No edit summary |
Kamal Akbar (talk | contribs) |
||
| Line 19: | Line 19: | ||
*Smoking<ref name="pmid23853208">{{cite journal| author=Metayer C, Zhang L, Wiemels JL, Bartley K, Schiffman J, Ma X et al.| title=Tobacco smoke exposure and the risk of childhood acute lymphoblastic and myeloid leukemias by cytogenetic subtype. | journal=Cancer Epidemiol Biomarkers Prev | year= 2013 | volume= 22 | issue= 9 | pages= 1600-11 | pmid=23853208 | doi=10.1158/1055-9965.EPI-13-0350 | pmc=3769478 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23853208 }} </ref><ref name="pmid24699944">{{cite journal| author=Farioli A, Legittimo P, Mattioli S, Miligi L, Benvenuti A, Ranucci A et al.| title=Tobacco smoke and risk of childhood acute lymphoblastic leukemia: findings from the SETIL case-control study. | journal=Cancer Causes Control | year= 2014 | volume= 25 | issue= 6 | pages= 683-92 | pmid=24699944 | doi=10.1007/s10552-014-0371-9 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24699944 }} </ref> | *Smoking<ref name="pmid23853208">{{cite journal| author=Metayer C, Zhang L, Wiemels JL, Bartley K, Schiffman J, Ma X et al.| title=Tobacco smoke exposure and the risk of childhood acute lymphoblastic and myeloid leukemias by cytogenetic subtype. | journal=Cancer Epidemiol Biomarkers Prev | year= 2013 | volume= 22 | issue= 9 | pages= 1600-11 | pmid=23853208 | doi=10.1158/1055-9965.EPI-13-0350 | pmc=3769478 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23853208 }} </ref><ref name="pmid24699944">{{cite journal| author=Farioli A, Legittimo P, Mattioli S, Miligi L, Benvenuti A, Ranucci A et al.| title=Tobacco smoke and risk of childhood acute lymphoblastic leukemia: findings from the SETIL case-control study. | journal=Cancer Causes Control | year= 2014 | volume= 25 | issue= 6 | pages= 683-92 | pmid=24699944 | doi=10.1007/s10552-014-0371-9 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24699944 }} </ref> | ||
* [[Down syndrome]] <ref name="pmid30428356">{{cite journal| author=Mowery CT, Reyes JM, Cabal-Hierro L, Higby KJ, Karlin KL, Wang JH et al.| title=Trisomy of a Down Syndrome Critical Region Globally Amplifies Transcription via HMGN1 Overexpression. | journal=Cell Rep | year= 2018 | volume= 25 | issue= 7 | pages= 1898-1911.e5 | pmid=30428356 | doi=10.1016/j.celrep.2018.10.061 | pmc=6321629 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30428356 }} </ref> | * [[Down syndrome]] <ref name="pmid30428356">{{cite journal| author=Mowery CT, Reyes JM, Cabal-Hierro L, Higby KJ, Karlin KL, Wang JH et al.| title=Trisomy of a Down Syndrome Critical Region Globally Amplifies Transcription via HMGN1 Overexpression. | journal=Cell Rep | year= 2018 | volume= 25 | issue= 7 | pages= 1898-1911.e5 | pmid=30428356 | doi=10.1016/j.celrep.2018.10.061 | pmc=6321629 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30428356 }} </ref> | ||
* [[Ataxia telangiectasia]] | * [[Ataxia telangiectasia]]<ref name="pmid23509889">{{cite journal| author=Bielorai B, Fisher T, Waldman D, Lerenthal Y, Nissenkorn A, Tohami T et al.| title=Acute lymphoblastic leukemia in early childhood as the presenting sign of ataxia-telangiectasia variant. | journal=Pediatr Hematol Oncol | year= 2013 | volume= 30 | issue= 6 | pages= 574-82 | pmid=23509889 | doi=10.3109/08880018.2013.777949 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23509889 }} </ref> | ||
* [[Bloom syndrome]] | * [[Bloom syndrome]] | ||
* [[X-linked agammaglobulinemia]] | * [[X-linked agammaglobulinemia]] | ||
Revision as of 15:21, 29 January 2019
|
Acute lymphoblastic leukemia Microchapters |
|
Differentiating Acute lymphoblastic leukemia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Acute lymphoblastic leukemia risk factors On the Web |
|
American Roentgen Ray Society Images of Acute lymphoblastic leukemia risk factors |
|
Directions to Hospitals Treating Acute lymphoblastic leukemia |
|
Risk calculators and risk factors for Acute lymphoblastic leukemia risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Raviteja Guddeti, M.B.B.S. [2] Carlos A Lopez, M.D. [3]
Overview
Common risk factors in the development of acute lymphoblastic leukemia are Down syndrome, ataxia telangiectasia, Bloom syndrome, X-linked agammaglobulinemia, Fanconi's anemia and severe combined immunodeficiency.
Risk Factors
Common risk factors in the development of acute lymphoblastic leukemia are Down syndrome, ataxia telangiectasia, Bloom syndrome, X-linked agammaglobulinemia, Fanconi's anemia severe combined immunodeficiency, Radiation exposure, exposure to benzene, and smoking.
Common risk factors
Acute lymphoblastic leukemia risk factors may include the following:
- Radiation exposure[1]
- Benzene exposure[2]
- Infections with the following viruses
- Previous use of chemotherapy drugs
- Smoking[4][5]
- Down syndrome [6]
- Ataxia telangiectasia[7]
- Bloom syndrome
- X-linked agammaglobulinemia
- Fanconi's anemia
- Severe combined immunodeficiency
Less common risk factors
- Exposure to paint
- Electromagnetic filed radiation exposure
- Obesity
References
- ↑ 1.0 1.1 Greaves MF (1997). "Aetiology of acute leukaemia". Lancet. 349 (9048): 344–9. PMID 9024390.
- ↑ Khalade A, Jaakkola MS, Pukkala E, Jaakkola JJ (2010). "Exposure to benzene at work and the risk of leukemia: a systematic review and meta-analysis". Environ Health. 9: 31. doi:10.1186/1476-069X-9-31. PMC 2903550. PMID 20584305.
- ↑ Guan H, Miao H, Ma N, Lu W, Luo B (2017). "Correlations between Epstein-Barr virus and acute leukemia". J Med Virol. 89 (8): 1453–1460. doi:10.1002/jmv.24797. PMID 28225168.
- ↑ Metayer C, Zhang L, Wiemels JL, Bartley K, Schiffman J, Ma X; et al. (2013). "Tobacco smoke exposure and the risk of childhood acute lymphoblastic and myeloid leukemias by cytogenetic subtype". Cancer Epidemiol Biomarkers Prev. 22 (9): 1600–11. doi:10.1158/1055-9965.EPI-13-0350. PMC 3769478. PMID 23853208.
- ↑ Farioli A, Legittimo P, Mattioli S, Miligi L, Benvenuti A, Ranucci A; et al. (2014). "Tobacco smoke and risk of childhood acute lymphoblastic leukemia: findings from the SETIL case-control study". Cancer Causes Control. 25 (6): 683–92. doi:10.1007/s10552-014-0371-9. PMID 24699944.
- ↑ Mowery CT, Reyes JM, Cabal-Hierro L, Higby KJ, Karlin KL, Wang JH; et al. (2018). "Trisomy of a Down Syndrome Critical Region Globally Amplifies Transcription via HMGN1 Overexpression". Cell Rep. 25 (7): 1898–1911.e5. doi:10.1016/j.celrep.2018.10.061. PMC 6321629. PMID 30428356.
- ↑ Bielorai B, Fisher T, Waldman D, Lerenthal Y, Nissenkorn A, Tohami T; et al. (2013). "Acute lymphoblastic leukemia in early childhood as the presenting sign of ataxia-telangiectasia variant". Pediatr Hematol Oncol. 30 (6): 574–82. doi:10.3109/08880018.2013.777949. PMID 23509889.